A carregar...
HER2/neu as a potential target for immunotherapy in gynecological carcinosarcomas
Carcinosarcomas of the female genital tract are rare tumors with aggressive clinical behavior. Trastuzumab, a humanized monoclonal antibody, acts by binding to HER2/neu extracellular domain and exhibits therapeutic efficacy in HER2/neu over-expressing cancers. Two uterine carcinosarcomas (UMMT-ARK-1...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3366047/ https://ncbi.nlm.nih.gov/pubmed/22498937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PGP.0b013e31823bb24d |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|